Clinical Trial Update: A Phase I Study, Evaluating the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase I trial evaluating PRJ1-3024 for safety, pharmacokinetics, and preliminary efficacy in patients with advanced solid tumors. The study is currently ACTIVE_…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• PRJ1-3024

Snippet

Sponsor: Zhuhai Yufan Biotechnologies Co., Ltd | Conditions: Advanced Solid Tumor, Advanced Solid Malignancies | Phase 1 | Status: ACTIVE_NOT_RECRUITING